Evaluating oritavancin for Gram-positive infections: a systematic review of on-label and off-label use.

Saved in:
Bibliographic Details
Title: Evaluating oritavancin for Gram-positive infections: a systematic review of on-label and off-label use.
Authors: Soriano A; Infectious Diseases Service, Hospital Clínic Barcelona, University of Barcelona, Spain.; IDIBAPS, Barcelona, Spain.; CIBERINF, CIBER in Infectious Diseases, ISCIII, Madrid, Spain., Tascini C; Infectious Disease Unit, Department of Medicine, University of Udine, Udine, Italy., Falcone M; Infectious Diseases Unit, Department of Clinical and Experimental Medicine, Pisa University Hospital, University of Pisa, Pisa, Italy., Morata L; Infectious Diseases Service, Hospital Clínic Barcelona, University of Barcelona, Spain.; IDIBAPS, Barcelona, Spain., Bongiovanni M; Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.; University of Southern Switzerland, Lugano, Switzerland., Pea F; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.; Clinical Pharmacology Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Viale P; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.; Infectious Diseases Unit, Department for Integrated Infectious Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Source: Drugs in context [Drugs Context] 2026 Mar 19; Vol. 15. Date of Electronic Publication: 2026 Mar 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Bioexcel Publishing Ltd Country of Publication: England NLM ID: 101262187 Publication Model: eCollection Cited Medium: Print ISSN: 1745-1981 (Print) Linking ISSN: 17404398 NLM ISO Abbreviation: Drugs Context Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1745-1981
DOI:10.7573/dic.2025-9-4